Johnson & Johnson and the maker of its Pinnacle metal-on-metal hip implants, DePuy Orthopaedics, have been in settlement talks to resolve thousands of individual lawsuits alleging the devices were defective.
In a personal injury accident where you are looking to receive compensation for your injuries, some type of insurance company will more than likely be involved.
The attorneys general of 46 states who sued Johnson & Johnson and its subsidiary DePuy Orthopaedics, Inc. over deceptive and misleading marketing practices reached a $120 million consent judgment.
You may have already heard, Ford is recalling more than 953,000 vehicles worldwide to replace Takata passenger air bag inflators because they can explode and hurl shrapnel.
This recall of Ford vehicles includes over 782,000 vehicles in the United States and is part of the largest series of recalls in U.S. history.
In 2018, the medical device industry and the FDA came under fire from:
December 20, 2018. FDA Commissioner, Scott Gottlieb, issued a statement on the new steps the FDA will take to strengthen the long-term safety oversight of Essure. In his statement, Gottlieb said the FDA will continue to evaluate the product’s long-term safety profile even after it has been discontinued in the US market.
We are proud to say that our team is involved in the community and charitable activities, working to improve its well-being. The Nash & Franciskato Law Firm would like to recognize Brian S. Franciskato for his contributions.
The Nash & Franciskato Law Firm congratulates Brian S. Franciskato and Randy W. James for once again making the Super Lawyers List.
November 27, 2018. An NBC News investigation focused on medical device dangers, specifically the Biomet M2a Magnum Hip Implants, came out this week asking the question, “how can a medical device deemed unsafe in another country still be sold in the US?”
“Forty-two years ago, Congress passed the law establishing the framework for evaluating the safety and effectiveness of medical devices.”
On Monday, November 26, 2018, the Food and Drug Administration announced that it plans to modernize its current process, the 510(k) clearance pathway, which is how a majority of the medical devices are reviewed and approved by the FDA today.
